Kala Pharmaceuticals's total assets for Q2 2025 were $36.05M, a decrease of -25.28% from the previous quarter. KALA total liabilities were $39.26M for the fiscal quarter, a -7.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.